$14.06
0.201.44%
At close: -
$14.06
0.000.00%
After Hours: Feb 21, 4:01 PM EDT
Comments
Loading...
Takeda Pharmaceutical Co (NYSE:TAK) Stock, Earnings Estimates, EPS, And Revenue
Takeda Pharmaceutical Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jan 30
EPS
$0.440
Quarterly Revenue
$7.51B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$4.58T
Analyze the earnings history of Takeda Pharmaceutical Co using advanced sorting and filters.
Data brought to you by Benzinga APIs
Takeda Pharmaceutical Co (TAK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-10-31 | $0.45 | $0.57 | -21.1 % |
| Q2 | 2020-10-29 | $0.47 | $0.98 | -52.0 % |
| Q4 | 2020-05-13 | $0.12 | $0.43 | -72.1 % |
Takeda Pharmaceutical Co (TAK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2020-10-29 | $7.47B | $7.56M | 98722.8 % |
| Q4 | 2020-05-13 | $7.08B | $7.48M | 94539.0 % |
FAQ
When is Takeda Pharmaceutical Co (NYSE:TAK) reporting earnings?
Takeda Pharmaceutical Co (TAK) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on January 30, 2025 for Q3.
What were the latest earnings per share (EPS) for Takeda Pharmaceutical Co (NYSE:TAK)?
The Actual EPS was $0.44, which beat the estimate of $0.00.
What were Takeda Pharmaceutical Co’s (NYSE:TAK) revenues?
The Actual Revenue was $7.5B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.